pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Pulmonology · news · pharmadog
← back to Pulmonology
News · Pulmonology
515
stories
Jul 2, 26
Roche’s KRAS G12C inhibitor beats rivals in head-to-head Phase 3 study
endpoints
Jul 2, 26
Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists
stat
Jul 2, 26
Breathing Circuit Set Correction: Hamilton Medical Updates Use Instructions for Breathing Circuit Set
fda medwatch
Jul 1, 26
FDA says Zyn can market its pouches as safer than cigarettes
stat
Jul 1, 26
Opinion: What Ebola and Marburg are teaching us about the next pandemic
stat
Jun 29, 26
FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing
fda press
Jun 29, 26
Theravance, after clinical setbacks, agrees to $929M buyout
biopharma dive
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 18, 26
Moderna flu vaccine wins unanimous support from FDA panel
biopharma dive
Jun 18, 26
cAMPfield lands $180M to build gut disease drug
biopharma dive
Jun 18, 26
Pfizer CFO to step down; Denali sells a regulatory fast-pass
biopharma dive
Jun 18, 26
Opinion: Congress should embrace strategic health diplomacy
stat
Jun 18, 26
Opinion: AI’s growing appetite for power is a public health issue. Here’s a fix
stat
Jun 16, 26
FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
biopharma dive
Jun 15, 26
Covid vaccination cut risk of adverse heart events, large study finds
stat
Jun 11, 26
Nonprofit buys experimental cancer drug to maintain patient access
stat
Jun 11, 26
Summit pulls $500M share sale a day after announcing it
biopharma dive
Jun 10, 26
OB-GYN association, deviating from CDC guidance, issues its own vaccine recommendations
stat
Jun 9, 26
Merck, Gilead report mixed outcomes in key lung cancer, HIV studies
biopharma dive
Jun 9, 26
Gilead and Merck’s latest trial success and flop
stat
Jun 9, 26
Trodelvy misses in lung cancer, but Gilead and Merck have an HIV success
endpoints
Jun 9, 26
STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more
stat
Jun 9, 26
GSK boosts cancer pipeline with $11B Nuvalent buyout
biopharma dive
Jun 9, 26
STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B
stat
Jun 9, 26
GSK to acquire Nuvalent and its two cancer drugs under FDA review for $10.6B
endpoints
Jun 8, 26
City banks nearly $100M for next-gen RNAi drugs
biopharma dive
Jun 8, 26
Tango data add to growing momentum for pancreatic cancer drugs
biopharma dive
Jun 8, 26
J&J to acquire Firefly, maker of ‘degrader’ antibody drugs, for $1B
biopharma dive
Jun 5, 26
Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?
biopharma dive
Jun 4, 26
STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
stat
← prev
page 13 of 18
next →
